Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Observational × dalpiciclib × 90 days × Clear all

Status

Sponsor Class

Study Type

Interventional 5 Observational 1

Sponsor

Cancer Type

Conditions

Advanced Breast Cancer 1

Interventions

Surveys and Questionnaires 50 Blood Specimen Collection 41 Specimen Handling 31 Observation 19 Radiotherapy 16 Interviews as Topic 15 Immune Checkpoint Inhibitors 10 Watchful Waiting 9 Biopsy 9 Magnetic Resonance Spectroscopy 8 Drug Therapy 8 Surgical Procedures, Operative 7 Data Collection 7 pembrolizumab 6 enzalutamide 6 Tomography, X-Ray Computed 6 Tissue Banks 6 Standard of Care 6 Immunotherapy 6 ribociclib 5 darolutamide 5 apalutamide 5 Therapeutics 5 Restraint, Physical 5 Nivolumab 5 Magnetic Resonance Imaging 5 Liquid Biopsy 5 Focus Groups 5 lenvatinib 4 durvalumab 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06301438 2026-02-03

Dalpiciclib in HR+/HER2- ABC

RenJi Hospital

Advanced Breast Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡